Stock listing
Jade Biosciences, Inc.
Selected listing: JBIO · NASDAQ · USD · US
Jade Biosciences, Inc. (NASDAQ:JBIO), Health Technology. Latest release Sep 30, 2026: Jade Biosciences Announces Preclinical Data Characterizing JADE301…
- Ticker
- NASDAQ:JBIO
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Jade Biosciences, Inc.
The company focuses on developing innovative solutions in the biosciences sector. Investors can find information about its operations, financial performance, and market activities on its dedicated public company page.
Latest news from Jade Biosciences, Inc.
Jade Biosciences Announces Preclinical Data Characterizing JADE301, a Potentially Best-in-Class, Half-Life-Extended Anti-IFN-β Monoclonal Antibody in Development for Dermatomyositis, at EADV 2026
September 29, 2026
Jade Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 10, 2026
Jade Biosciences Announces Appointment of Mark Eisner, M.D., M.P.H., to Board of Directors
June 26, 2026
Jade Biosciences Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
June 5, 2026
Jade Biosciences Announces Pricing of Public Offering of Common Stock
June 3, 2026
Research Jade Biosciences, Inc.
Jade Biosciences, Inc. company profile
View the public company page for Jade Biosciences, Inc. on 6ix.
Jade Biosciences, Inc. news
Read company news and market updates connected to Jade Biosciences, Inc..
Jade Biosciences, Inc. investor events
Find investor webinars, events, and replay context for Jade Biosciences, Inc..